| Hazard ratios (95% CI)* | ||
---|---|---|---|
All-cause exit | Mortality | LTFU | |
Sex | |||
Female | 1.0 | 1.0 | 1.0 |
Male | 1.10 (1.04, 1.17) | 1.47 (1.25, 1.73) | 1.08 (1.00, 1.16) |
State | |||
Benue | 1.0 | 1.0 | 1.0 |
FCT | 2.61 (1.87, 3.65) | 0.99 (0.48, 2.01) | 5.22 (2.96, 9.22) |
Nasarawa | 1.97 (1.41, 2.75) | 0.94 (0.45, 1.91) | 3.66 (2.08, 6.46) |
Pregnancy status | |||
Not pregnant | 1.0 | 1.0 | 1.0 |
Pregnant | 1.09 (0.92, 1.30) | 0.94 (0.48, 2.01) | 1.08 (0.87, 1.33) |
Breastfeeding | 0.64 (0.50, 0.81) | 0.32 (0.10, 1.01) | 0.62 (0.46, 0.83) |
Age at ART start†| |||
1st quartile | 1.0 | 1.0 | 1.0 |
2nd quartile | 0.98 (0.91, 1.06) | 0.69 (0.57, 0.84) | 1.07 (0.97, 1.18) |
3rd quartile | 0.10 (0.92, 1.08) | 0.62 (0.50, 0.77) | 1.12 (1.01, 1.24) |
4th quartile | 1.16 (1.07, 1.26) | 0.54 (0.42, 0.68) | 1.38 (1.25, 1.53) |
ARV refill duration | |||
3Â months | 1.0 | 1.0 | 1.0 |
2Â months | 1.13 (1.02, 1.24) | 1.40 (0.99, 1.98) | 1.03 (0.91, 1.17) |
1Â month | 2.21 (2.01, 2.43) | 3.34 (2.40, 4.62) | 2.21 (1.97, 2.49) |
Contact tested | |||
No | 1.0 | 1.0 | 1.0 |
Yes | 0.40 (0.36, 0.44) | 0.42 (0.31, 0.56) | 0.37 (0.32, 0.42) |
Facility support model | |||
Standard | 1.0 | 1.0 | 1.0 |
Model | 0.86 (0.81, 0.91) | 1.12 (0.96, 1.31) | 0.78 (0.73, 0.83) |